Skip to main content
Erschienen in: Diabetology International 3/2019

19.11.2018 | Original Article

Low muscle mass and inflammation among patients with type 2 diabetes mellitus in Indonesia

verfasst von: Perdana Samekto Tyasnugroho Suyoto, Bianda Aulia

Erschienen in: Diabetology International | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Chronic inflammation, as observed in type 2 diabetes mellitus (T2DM), is associated with complications. How chronic inflammation influences body composition in patients with T2DM remains to be investigated. Our study aimed to evaluate the difference of skeletal muscle mass between patients with and without inflammation indicated by plasma high sensitivity C-reactive protein (hs-CRP).

Methods

Patients with T2DM were recruited from primary health care in Sleman district, Indonesia. Measurements were performed to obtain information on body weight, body mass index, waist circumference, waist-to-height ratio, total body fat, subcutaneous fat, visceral fat, mid-upper arm circumference, and muscle mass. Spearman’s rank correlation was performed to test the correlation between hs-CRP level and several components of body composition. To test the difference of percent skeletal muscle mass between subjects with and without inflammation (hs-CRP ≥ 3 or < 3 mg/dL), general linear model was utilized with adjustment for several variables. Analysis with p value of less than 0.05 is considered statistically significant.

Result

In all subjects, hs-CRP is correlated with skeletal muscle mass (r: − 0.343; p = 0.04), total body fat (r: 0.353; p = 0.04), and subcutaneous fat (r: 0.369; p = 0.02) but not visceral fat (p: − 0.065; p = ns). Significant difference of skeletal muscle mass between subjects with and without inflammation was found in all and female subjects after adjustment for covariates.

Conclusion

There was a negative correlation between skeletal muscle mass percentage and inflammation indicated by hs-CRP in type 2 diabetes patients.
Literatur
2.
Zurück zum Zitat Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36:166–75.CrossRefPubMed Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36:166–75.CrossRefPubMed
3.
Zurück zum Zitat Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171–82.CrossRefPubMed Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171–82.CrossRefPubMed
4.
Zurück zum Zitat Li JP, Lu L, Wang LJ, Zhang FR, Shen WF. Increased serum levels of S100B are related to the severity of cardiac dysfunction, renal insufficiency and major cardiac events in patients with chronic heart failure. Clin Biochem. 2011;44:984–8.CrossRefPubMed Li JP, Lu L, Wang LJ, Zhang FR, Shen WF. Increased serum levels of S100B are related to the severity of cardiac dysfunction, renal insufficiency and major cardiac events in patients with chronic heart failure. Clin Biochem. 2011;44:984–8.CrossRefPubMed
5.
Zurück zum Zitat Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23:507–15.CrossRefPubMedPubMedCentral Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23:507–15.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Wang J, Leung K-S, Chow SK-H, Cheung W-H. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Transl. 2017;10:94–101. Wang J, Leung K-S, Chow SK-H, Cheung W-H. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Transl. 2017;10:94–101.
9.
Zurück zum Zitat Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 2007;56:1592–9.CrossRefPubMed Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 2007;56:1592–9.CrossRefPubMed
10.
Zurück zum Zitat Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45–56.CrossRefPubMed Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45–56.CrossRefPubMed
11.
Zurück zum Zitat Kalyani RR, Metter EJ, Ramachandran R, Chia CW, Saudek CD, Ferrucci L. Glucose and insulin measurements from the oral glucose tolerance test and relationship to muscle mass. J Gerontol Ser A Biomed Sci Med Sci. 2011;67:74–81. Kalyani RR, Metter EJ, Ramachandran R, Chia CW, Saudek CD, Ferrucci L. Glucose and insulin measurements from the oral glucose tolerance test and relationship to muscle mass. J Gerontol Ser A Biomed Sci Med Sci. 2011;67:74–81.
13.
Zurück zum Zitat Ashwell M, Gibson S. Waist-to-height ratio as an indicator of ‘early health risk’: simpler and more predictive than using a ‘matrix’ based on BMI and waist circumference. BMJ Open. 2016;6:e010159.CrossRefPubMedPubMedCentral Ashwell M, Gibson S. Waist-to-height ratio as an indicator of ‘early health risk’: simpler and more predictive than using a ‘matrix’ based on BMI and waist circumference. BMJ Open. 2016;6:e010159.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569–74.CrossRefPubMed Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569–74.CrossRefPubMed
15.
Zurück zum Zitat Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10:e0121971.CrossRefPubMedPubMedCentral Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10:e0121971.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327.CrossRefPubMed Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327.CrossRefPubMed
17.
Zurück zum Zitat Clarke R, Valdes-Marquez E, Hill M, Gordon J, Farrall M, Hamsten A, et al. Plasma cytokines and risk of coronary heart disease in the PROCARDIS study. Open Hear. 2018;5:e000807.CrossRef Clarke R, Valdes-Marquez E, Hill M, Gordon J, Farrall M, Hamsten A, et al. Plasma cytokines and risk of coronary heart disease in the PROCARDIS study. Open Hear. 2018;5:e000807.CrossRef
18.
Zurück zum Zitat Aryan Z, Ghajar A, Faghihi-Kashani S, Afarideh M, Nakhjavani M, Esteghamati A. Baseline high-sensitivity c-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: a population-based study. Ann Nutr Metab. 2018;72:287–95.CrossRefPubMed Aryan Z, Ghajar A, Faghihi-Kashani S, Afarideh M, Nakhjavani M, Esteghamati A. Baseline high-sensitivity c-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: a population-based study. Ann Nutr Metab. 2018;72:287–95.CrossRefPubMed
19.
Zurück zum Zitat Kadi F, Nilsson A, Wåhlin-Larsson B, Bergens O. Chronic systemic inflammation, physical activity and skeletal muscle in elderly. Med Sci Sport Exerc. 2017;49:234.CrossRef Kadi F, Nilsson A, Wåhlin-Larsson B, Bergens O. Chronic systemic inflammation, physical activity and skeletal muscle in elderly. Med Sci Sport Exerc. 2017;49:234.CrossRef
20.
Zurück zum Zitat Alemán H, Esparza J, Ramirez FA, Astiazaran H, Payette H. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing. 2011;40:469–75.CrossRefPubMed Alemán H, Esparza J, Ramirez FA, Astiazaran H, Payette H. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing. 2011;40:469–75.CrossRefPubMed
22.
Zurück zum Zitat Westbury LD, Fuggle NR, Syddall HE, Duggal NA, Shaw SC, Maslin K, et al. Relationships between markers of inflammation and muscle mass, strength and function: findings from the Hertfordshire cohort study. Calcif Tissue Int [Internet]. 2018;102:287–95. http://www.ncbi.nlm.nih.gov/pubmed/29101476. Accessed 31 May 2018. Westbury LD, Fuggle NR, Syddall HE, Duggal NA, Shaw SC, Maslin K, et al. Relationships between markers of inflammation and muscle mass, strength and function: findings from the Hertfordshire cohort study. Calcif Tissue Int [Internet]. 2018;102:287–95. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​29101476. Accessed 31 May 2018.
23.
24.
Zurück zum Zitat Pellegrinelli V, Rouault C, Rodriguez-Cuenca S, Albert V, Edom-Vovard F, Vidal-Puig A, et al. Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes. 2015;64:3121–34.CrossRefPubMed Pellegrinelli V, Rouault C, Rodriguez-Cuenca S, Albert V, Edom-Vovard F, Vidal-Puig A, et al. Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes. 2015;64:3121–34.CrossRefPubMed
26.
Zurück zum Zitat Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5:e10805.CrossRefPubMedPubMedCentral Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5:e10805.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol. 2012;2012:1–10.CrossRef Sakuma K, Yamaguchi A. Sarcopenia and age-related endocrine function. Int J Endocrinol. 2012;2012:1–10.CrossRef
31.
Zurück zum Zitat Patani S, Nayak M, Sharma R. Study of relation between hyperglycemia and inflammation in type 2 diabetes. Mellitus. 2018;14:1–4. Patani S, Nayak M, Sharma R. Study of relation between hyperglycemia and inflammation in type 2 diabetes. Mellitus. 2018;14:1–4.
35.
Zurück zum Zitat Lee SW, Youm Y, Lee WJ, Choi W, Chu SH, Park YR, et al. Appendicular skeletal muscle mass and insulin resistance in an elderly Korean population: the Korean Social Life, Health And Aging Project-health examination cohort. Diabetes Metab J. 2015;39:37–45.CrossRefPubMedPubMedCentral Lee SW, Youm Y, Lee WJ, Choi W, Chu SH, Park YR, et al. Appendicular skeletal muscle mass and insulin resistance in an elderly Korean population: the Korean Social Life, Health And Aging Project-health examination cohort. Diabetes Metab J. 2015;39:37–45.CrossRefPubMedPubMedCentral
Metadaten
Titel
Low muscle mass and inflammation among patients with type 2 diabetes mellitus in Indonesia
verfasst von
Perdana Samekto Tyasnugroho Suyoto
Bianda Aulia
Publikationsdatum
19.11.2018
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 3/2019
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-018-0384-9

Weitere Artikel der Ausgabe 3/2019

Diabetology International 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.